|
Harrow Health ، Inc. (HROW) تقييم DCF |
Fully Editable: Tailor To Your Needs In Excel Or Sheets
Professional Design: Trusted, Industry-Standard Templates
Investor-Approved Valuation Models
MAC/PC Compatible, Fully Unlocked
No Expertise Is Needed; Easy To Follow
Harrow Health, Inc. (HROW) Bundle
اكتشف الإمكانات الحقيقية لـ Harrow Health ، Inc. (HROW) مع حاسبة DCF المتقدمة! اضبط الافتراضات الرئيسية واستكشاف السيناريوهات المختلفة وتقييم كيفية تأثير التغييرات على تقييم Harrow Health-كل ذلك ضمن قالب Excel سهل الاستخدام.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 48.9 | 72.5 | 88.6 | 130.2 | 199,614,000.0 | 308,151,159.4 | 475,703,793.4 | 734,360,693.4 | 1,133,658,456.2 | 1,750,068,470.1 |
| Revenue Growth, % | 0 | 48.3 | 22.24 | 46.95 | 153321507 | 54.37 | 54.37 | 54.37 | 54.37 | 54.37 |
| EBITDA | 3.5 | -10.1 | -3.2 | 9.7 | 8,822,000.0 | 875,557.9 | 1,351,629.5 | 2,086,558.0 | 3,221,093.1 | 4,972,514.8 |
| EBITDA, % | 7.14 | -13.99 | -3.62 | 7.47 | 4.42 | 0.28413 | 0.28413 | 0.28413 | 0.28413 | 0.28413 |
| Depreciation | 2.7 | 2.4 | 3.7 | 12.3 | 14.5 | 13,887,573.6 | 21,438,736.3 | 33,095,731.9 | 51,091,046.5 | 78,871,047.2 |
| Depreciation, % | 5.61 | 3.31 | 4.14 | 9.48 | 0.000007282555 | 4.51 | 4.51 | 4.51 | 4.51 | 4.51 |
| EBIT | .7 | -12.5 | -6.9 | -2.6 | 8,821,985.5 | -13,012,015.7 | -20,087,106.8 | -31,009,173.9 | -47,869,953.4 | -73,898,532.4 |
| EBIT, % | 1.53 | -17.3 | -7.75 | -2.01 | 4.42 | -4.22 | -4.22 | -4.22 | -4.22 | -4.22 |
| Total Cash | 32.6 | 50.7 | 96.3 | 82.8 | 47,247,000.0 | 199,540,169.8 | 308,037,185.0 | 475,527,847.2 | 734,089,079.0 | 1,133,239,155.5 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 2.7 | 4.5 | 6.4 | 36.5 | 116,373,000.0 | 64,845,474.6 | 100,104,242.1 | 154,534,442.8 | 238,560,259.9 | 368,273,871.9 |
| Account Receivables, % | 5.45 | 6.23 | 7.21 | 28.03 | 58.3 | 21.04 | 21.04 | 21.04 | 21.04 | 21.04 |
| Inventories | 4.0 | 4.2 | 6.5 | 10.9 | 10,702,000.0 | 21,580,908.3 | 33,315,208.0 | 51,429,859.4 | 79,394,084.6 | 122,563,443.6 |
| Inventories, % | 8.11 | 5.82 | 7.38 | 8.35 | 5.36 | 7 | 7 | 7 | 7 | 7 |
| Accounts Payable | 3.6 | 5.2 | 6.4 | 21.4 | 38.8 | 23,617,905.6 | 36,459,792.4 | 56,284,265.1 | 86,888,001.6 | 134,132,067.0 |
| Accounts Payable, % | 7.46 | 7.14 | 7.27 | 16.46 | 0.000019418478 | 7.66 | 7.66 | 7.66 | 7.66 | 7.66 |
| Capital Expenditure | -1.0 | -28.5 | -7.8 | -152.6 | -38.7 | -92,536,251.0 | -142,851,468.4 | -220,524,841.0 | -340,431,960.8 | -525,536,803.1 |
| Capital Expenditure, % | -2.03 | -39.34 | -8.77 | -117.17 | -0.000019374393 | -30.03 | -30.03 | -30.03 | -30.03 | -30.03 |
| Tax Rate, % | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
| EBITAT | .7 | -12.6 | -6.9 | -2.7 | 8.9 | -10,409,615.2 | -16,069,689.5 | -24,807,345.4 | -38,295,972.4 | -59,118,840.9 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -.5 | -39.3 | -13.9 | -162.4 | -127,074,950.5 | -24,791,808.7 | -171,633,602.0 | -264,956,833.9 | -409,023,192.5 | -631,423,502.3 |
| WACC, % | 7.06 | 7.06 | 7.06 | 7.06 | 4.97 | 6.64 | 6.64 | 6.64 | 6.64 | 6.64 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -1,166,569,433.6 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | -656,680,442 | |||||||||
| Terminal Value | -24,828,025,891 | |||||||||
| Present Terminal Value | -17,998,711,098 | |||||||||
| Enterprise Value | -19,165,280,532 | |||||||||
| Net Debt | 182 | |||||||||
| Equity Value | -19,165,280,713 | |||||||||
| Diluted Shares Outstanding, MM | 36 | |||||||||
| Equity Value Per Share | -537,584,765.00 |
What You Will Receive
- Comprehensive Financial Model: Harrow Health’s actual data facilitates accurate DCF valuation.
- Complete Forecast Customization: Modify revenue growth, profit margins, WACC, and other essential factors.
- Real-Time Calculations: Automatic updates provide immediate insights as you make adjustments.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
- Flexible and Reusable: Designed for adaptability, allowing for repeated use in detailed forecasting.
Key Features
- 🔍 Real-Life HROW Financials: Pre-filled historical and projected data for Harrow Health, Inc. (HROW).
- ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
- 📊 Professional DCF Valuation: Built-in formulas calculate Harrow Health’s intrinsic value using the Discounted Cash Flow method.
- ⚡ Instant Results: Visualize Harrow Health’s valuation instantly after making changes.
- Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.
How It Works
- Step 1: Download the Excel file for Harrow Health, Inc. (HROW).
- Step 2: Review Harrow Health’s pre-filled financial data and forecasts.
- Step 3: Modify key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
- Step 4: Observe the DCF model update in real-time as you adjust your assumptions.
- Step 5: Analyze the outputs and utilize the results for your investment decisions.
Why Choose This Calculator for Harrow Health, Inc. (HROW)?
- User-Friendly Interface: Crafted for both novices and seasoned professionals.
- Customizable Inputs: Adjust parameters easily to suit your financial analysis.
- Real-Time Valuation: Witness immediate updates to Harrow Health’s valuation as you modify inputs.
- Preloaded Data: Comes with Harrow Health’s actual financial metrics for swift evaluations.
- Preferred by Experts: Utilized by investors and analysts for informed decision-making.
Who Should Use This Product?
- Healthcare Investors: Develop comprehensive valuation models for analyzing investments in Harrow Health, Inc. (HROW).
- Corporate Strategy Teams: Evaluate valuation scenarios to inform strategic decisions within healthcare sectors.
- Consultants and Advisors: Deliver precise valuation insights for clients interested in Harrow Health, Inc. (HROW).
- Students and Educators: Utilize real-time data to enhance learning and practice in financial modeling.
- Health Industry Enthusiasts: Gain insights into how companies like Harrow Health, Inc. (HROW) are valued in the healthcare market.
What the Template Contains
- Historical Data: Includes Harrow Health, Inc.'s (HROW) past financials and baseline forecasts.
- DCF and Levered DCF Models: Detailed templates to calculate Harrow Health, Inc.'s (HROW) intrinsic value.
- WACC Sheet: Pre-built calculations for Weighted Average Cost of Capital.
- Editable Inputs: Modify key drivers like growth rates, EBITDA %, and CAPEX assumptions.
- Quarterly and Annual Statements: A complete breakdown of Harrow Health, Inc.'s (HROW) financials.
- Interactive Dashboard: Visualize valuation results and projections dynamically.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.